Development of primary central nervous system lymphoma in a systemic lupus erythematosus patient after treatment with mycophenolate mofetil and review of the literature
dc.authorid | BALCI, Mehmet Ali/0000-0003-0597-7788 | |
dc.authorwosid | BALCI, Mehmet Ali/M-7089-2015 | |
dc.contributor.author | Balci, M. A. | |
dc.contributor.author | Pamuk, G. E. | |
dc.contributor.author | Unlu, E. | |
dc.contributor.author | Usta, U. | |
dc.contributor.author | Pamuk, O. N. | |
dc.date.accessioned | 2024-06-12T11:15:57Z | |
dc.date.available | 2024-06-12T11:15:57Z | |
dc.date.issued | 2017 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Primary central nervous system lymphoma (PCNSL) is a rare form of extranodal non-Hodgkin lymphoma and four cases of PCNSL have previously been described in association with mycophenolate mofetil. We report the fifth case of PCNSL in a patient with lupus nephropathy while on mycophenolate mofetil treatment. | en_US |
dc.identifier.doi | 10.1177/0961203317691370 | |
dc.identifier.endpage | 1227 | en_US |
dc.identifier.issn | 0961-2033 | |
dc.identifier.issn | 1477-0962 | |
dc.identifier.issue | 11 | en_US |
dc.identifier.pmid | 28152659 | en_US |
dc.identifier.scopus | 2-s2.0-85028974831 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 1224 | en_US |
dc.identifier.uri | https://doi.org/10.1177/0961203317691370 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/24137 | |
dc.identifier.volume | 26 | en_US |
dc.identifier.wos | WOS:000410124100013 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Sage Publications Ltd | en_US |
dc.relation.ispartof | Lupus | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Systemic Lupus Erythematosus | en_US |
dc.subject | Nephritis | en_US |
dc.subject | Haematological Changes | en_US |
dc.subject | Nephritis | en_US |
dc.subject | Cohort | en_US |
dc.title | Development of primary central nervous system lymphoma in a systemic lupus erythematosus patient after treatment with mycophenolate mofetil and review of the literature | en_US |
dc.type | Review Article | en_US |